Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2021
June 21, 2021 at 06:15 am EDT
Share
Advanced Biomedical Technologies, Inc. announced earnings results for the second quarter ended April 30, 2021. For the second quarter, the company announced sales was USD 95 compared to negative sales of USD 211 a year ago. Operating loss was USD 113,150 compared to USD 120,334 a year ago. Net loss was USD 189,089 compared to USD 209,652 a year ago. For the half year, sales was USD 47,328 compared to USD 60,290 a year ago. Operating loss was USD 201,792 compared to USD 219,979 a year ago. Net loss was USD 361,133 compared to USD 273,441 a year ago. Basic loss per share from continuing operations was USD 0.01.
Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing, manufacturing, and marketing of biomaterial internal fixation devices. The Companyâs primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
ADVANCED BIOMEDICAL TECHNOLOGIES, INC. 
